sorbitol has been researched along with clindamycin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jennings, CA; Siddiqi, M | 1 |
Borsiczky, B; Cseh, G; Frank, D; Juricskay, I; Kocsis, B; Kovács, GL; Miseta, A; Montskó, G; Nagy, ÁK; Nagy, T | 1 |
1 review(s) available for sorbitol and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for sorbitol and clindamycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A near-fatal overdose of carisoprodol (SOMA): case report.
Topics: Adult; Antidotes; Carisoprodol; Charcoal; Chlordiazepoxide; Clindamycin; Drug Overdose; Drug Therapy, Combination; Flumazenil; Gastric Lavage; Humans; Male; Muscle Relaxants, Central; Naloxone; Sodium Bicarbonate; Sorbitol; Temazepam; Treatment Outcome | 2004 |
Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system: a new potential treatment option for chronic osteomyelitis.
Topics: Anti-Bacterial Agents; Capsules; Chromatography, High Pressure Liquid; Chronic Disease; Clindamycin; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Health Care Costs; Kinetics; Osteomyelitis; Polymethyl Methacrylate; Solubility; Sorbitol | 2011 |